Clinical Trials
2
Active:1
Completed:0
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED
Phase 2
Active, not recruiting
- Conditions
- Persistent Corneal Epithelial Defect
- Interventions
- Drug: KPI-012 Vehicle
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2025-09-30
- Lead Sponsor
- Combangio, Inc
- Target Recruit Count
- 2
- Registration Number
- NCT05727878
- Locations
- 🇵🇷
Principal Investigator, San Juan, Puerto Rico, Puerto Rico
🇺🇸Principal investigator, Durham, North Carolina, United States
News
No news found